Skip to main content
Top
Published in: BMC Infectious Diseases 1/2014

Open Access 01-12-2014 | Research article

Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico

Authors: Cosme Alvarado-Esquivel, Jesús Hernández-Tinoco, Luis Francisco Sánchez-Anguiano, Agar Ramos-Nevárez, Sandra Margarita Cerrillo-Soto, Sergio Estrada-Martínez, Lucio Martínez-Ramírez, Alma Rosa Pérez-Álamos, Carlos Alberto Guido-Arreola

Published in: BMC Infectious Diseases | Issue 1/2014

Login to get access

Abstract

Background

Cytomegalovirus causes congenital infections all around the world. The seroepidemiology of cytomegalovirus infection in pregnant women in Mexico is largely unknown. We sought to determine the seroprevalence of cytomegalovirus infection in pregnant women in Durango City, Mexico; and to determine seroprevalence association with socio-demographic, clinical and behavioral characteristics of pregnant women.

Methods

Through a cross-sectional study design, 343 pregnant women were examined for anti-cytomegalovirus IgG and IgM antibodies in Durango City, Mexico. We used a standardized questionnaire to obtain the general characteristics of the pregnant women. Multivariate analysis was performed to determine the association of cytomegalovirus infection with the characteristics of the pregnant women.

Results

Anti-CMV IgG and IgM antibodies were detected in 225 (65.6%) and in none of the 343 pregnant women studied, respectively. Multivariate analysis showed that CMV exposure was associated with increasing age (OR = 1.67; 95% CI: 1.01-2.76; P = 0.04). Other women characteristics including socioeconomic status, education, blood transfusion, transplantation, sexual promiscuity and number of previous pregnancies or deliveries did not show an association with CMV exposure.

Conclusions

This is the first seroepidemiology study of CMV infection in pregnant women in Mexico. A number of known factors associated with CMV infection were not associated with CMV exposure in the women studied. Further studies to determine routes of CMV infection in pregnant women in Mexico are needed.
Literature
1.
go back to reference de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA: Summary of the II International Symposium on Cytomegalovirus. Antiviral Res. 1998, 39: 141-162. 10.1016/S0166-3542(98)00044-8.CrossRefPubMed de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA: Summary of the II International Symposium on Cytomegalovirus. Antiviral Res. 1998, 39: 141-162. 10.1016/S0166-3542(98)00044-8.CrossRefPubMed
2.
go back to reference Hyde TB, Schmid DS, Cannon MJ: Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol. 2010, 20: 311-326. 10.1002/rmv.659. doi:10.1002/rmv.659CrossRefPubMed Hyde TB, Schmid DS, Cannon MJ: Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol. 2010, 20: 311-326. 10.1002/rmv.659. doi:10.1002/rmv.659CrossRefPubMed
3.
go back to reference Kenneson A, Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007, 17: 253-276. 10.1002/rmv.535.CrossRefPubMed Kenneson A, Cannon MJ: Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007, 17: 253-276. 10.1002/rmv.535.CrossRefPubMed
4.
go back to reference Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK: The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013, 26: 86-102. 10.1128/CMR.00062-12. doi:10.1128/CMR.00062-12CrossRefPubMedPubMedCentral Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK: The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013, 26: 86-102. 10.1128/CMR.00062-12. doi:10.1128/CMR.00062-12CrossRefPubMedPubMedCentral
5.
go back to reference Buonsenso D, Serranti D, Gargiullo L, Ceccarelli M, Ranno O, Valentini P: Congenital cytomegalovirus infection: current strategies and future perspectives. Eur Rev Med Pharmacol Sci. 2012, 16: 919-935.PubMed Buonsenso D, Serranti D, Gargiullo L, Ceccarelli M, Ranno O, Valentini P: Congenital cytomegalovirus infection: current strategies and future perspectives. Eur Rev Med Pharmacol Sci. 2012, 16: 919-935.PubMed
6.
go back to reference Swanson EC, Schleiss MR: Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am. 2013, 60: 335-349. 10.1016/j.pcl.2012.12.008. doi:10.1016/j.pcl.2012.12.008CrossRefPubMed Swanson EC, Schleiss MR: Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr Clin North Am. 2013, 60: 335-349. 10.1016/j.pcl.2012.12.008. doi:10.1016/j.pcl.2012.12.008CrossRefPubMed
7.
go back to reference Goodrum F, Caviness K, Zagallo P: Human cytomegalovirus persistence. Cell Microbiol. 2012, 14: 644-655. 10.1111/j.1462-5822.2012.01774.x. doi:10.1111/j.1462-5822.2012.01774.xCrossRefPubMedPubMedCentral Goodrum F, Caviness K, Zagallo P: Human cytomegalovirus persistence. Cell Microbiol. 2012, 14: 644-655. 10.1111/j.1462-5822.2012.01774.x. doi:10.1111/j.1462-5822.2012.01774.xCrossRefPubMedPubMedCentral
8.
go back to reference Cannon MJ, Schmid DS, Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010, 20: 202-213. 10.1002/rmv.655. doi:10.1002/rmv.655CrossRefPubMed Cannon MJ, Schmid DS, Hyde TB: Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010, 20: 202-213. 10.1002/rmv.655. doi:10.1002/rmv.655CrossRefPubMed
9.
go back to reference Lindholm PF, Annen K, Ramsey G: Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets. 2011, 11: 45-56. 10.2174/187152611794407746.CrossRefPubMed Lindholm PF, Annen K, Ramsey G: Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets. 2011, 11: 45-56. 10.2174/187152611794407746.CrossRefPubMed
10.
go back to reference Foti G, Hyeraci M, Kunkar A, Ieropoli G, Sofo D, De Lorenzo S, Carpentieri MS: Cytomegalovirus infection in the adult. Minerva Med. 2002, 93: 109-117.PubMed Foti G, Hyeraci M, Kunkar A, Ieropoli G, Sofo D, De Lorenzo S, Carpentieri MS: Cytomegalovirus infection in the adult. Minerva Med. 2002, 93: 109-117.PubMed
11.
go back to reference Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E: Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine. 2013, 31: 5067-5074. 10.1016/j.vaccine.2013.08.077. doi:10.1016/j.vaccine.2013.08.077CrossRefPubMed Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E: Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine. 2013, 31: 5067-5074. 10.1016/j.vaccine.2013.08.077. doi:10.1016/j.vaccine.2013.08.077CrossRefPubMed
12.
go back to reference Echániz-Avilés G, Tamayo-Legorreta E, Cruz-Valdez A, Rangel-Flores H, Hernández-Nevárez P, Gatica-Marquina R, Calderón-Jaimes E: Prevalence of antibodies against cytomegalovirus in women of reproductive age. Salud Publica Mex. 1993, 35: 20-26.PubMed Echániz-Avilés G, Tamayo-Legorreta E, Cruz-Valdez A, Rangel-Flores H, Hernández-Nevárez P, Gatica-Marquina R, Calderón-Jaimes E: Prevalence of antibodies against cytomegalovirus in women of reproductive age. Salud Publica Mex. 1993, 35: 20-26.PubMed
13.
go back to reference Wujcicka W, Gaj Z, Wilczyński J, Sobala W, Spiewak E, Nowakowska D: Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis. 2014, in press Wujcicka W, Gaj Z, Wilczyński J, Sobala W, Spiewak E, Nowakowska D: Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis. 2014, in press
14.
go back to reference Taniguchi K, Watanabe N, Sato A, Jwa SC, Suzuki T, Yamanobe Y, Sago H, Kozuka K: Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol. 2014, 59: 192-194. 10.1016/j.jcv.2013.12.013. doi:10.1016/j.jcv.2013.12.013CrossRefPubMed Taniguchi K, Watanabe N, Sato A, Jwa SC, Suzuki T, Yamanobe Y, Sago H, Kozuka K: Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol. 2014, 59: 192-194. 10.1016/j.jcv.2013.12.013. doi:10.1016/j.jcv.2013.12.013CrossRefPubMed
15.
go back to reference Barlinn R, Vainio K, Samdal HH, Nordbø SA, Nøkleby H, Dudman SG: Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014, 86: 820-826. 10.1002/jmv.23757. doi:10.1002/jmv.23757CrossRefPubMed Barlinn R, Vainio K, Samdal HH, Nordbø SA, Nøkleby H, Dudman SG: Susceptibility to cytomegalovirus, parvovirus B19 and age-dependent differences in levels of rubella antibodies among pregnant women. J Med Virol. 2014, 86: 820-826. 10.1002/jmv.23757. doi:10.1002/jmv.23757CrossRefPubMed
16.
go back to reference Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ: Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013, 8: e81881-10.1371/journal.pone.0081881. doi:10.1371/journal.pone.0081881CrossRefPubMedPubMedCentral Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ: Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013, 8: e81881-10.1371/journal.pone.0081881. doi:10.1371/journal.pone.0081881CrossRefPubMedPubMedCentral
17.
go back to reference Enders G, Daiminger A, Lindemann L, Knotek F, Bäder U, Exler S, Enders M: Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol. 2012, 201: 303-309. 10.1007/s00430-012-0232-7. doi:10.1007/s00430-012-0232-7CrossRefPubMed Enders G, Daiminger A, Lindemann L, Knotek F, Bäder U, Exler S, Enders M: Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Med Microbiol Immunol. 2012, 201: 303-309. 10.1007/s00430-012-0232-7. doi:10.1007/s00430-012-0232-7CrossRefPubMed
18.
go back to reference Erfanianahmadpoor M, Nasiri R, Vakili R, Hassannia T: Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study. Saudi Med J. 2014, 35: 360-364.PubMed Erfanianahmadpoor M, Nasiri R, Vakili R, Hassannia T: Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study. Saudi Med J. 2014, 35: 360-364.PubMed
19.
go back to reference Neirukh T, Qaisi A, Saleh N, Rmaileh AA, Zahriyeh EA, Qurei L, Dajani F, Nusseibeh T, Khamash H, Baraghithi S, Azzeh M: Seroprevalence of cytomegalovirus among pregnant women and hospitalized children in Palestine. BMC Infect Dis. 2013, 13: 528-10.1186/1471-2334-13-528. doi:10.1186/1471-2334-13-528CrossRefPubMedPubMedCentral Neirukh T, Qaisi A, Saleh N, Rmaileh AA, Zahriyeh EA, Qurei L, Dajani F, Nusseibeh T, Khamash H, Baraghithi S, Azzeh M: Seroprevalence of cytomegalovirus among pregnant women and hospitalized children in Palestine. BMC Infect Dis. 2013, 13: 528-10.1186/1471-2334-13-528. doi:10.1186/1471-2334-13-528CrossRefPubMedPubMedCentral
20.
go back to reference Yamamoto AY, Castellucci RA, Aragon DC, Mussi-Pinhata MM: Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol Infect. 2013, 141: 2187-2191. 10.1017/S0950268812002695. doi:10.1017/S0950268812002695CrossRefPubMed Yamamoto AY, Castellucci RA, Aragon DC, Mussi-Pinhata MM: Early high CMV seroprevalence in pregnant women from a population with a high rate of congenital infection. Epidemiol Infect. 2013, 141: 2187-2191. 10.1017/S0950268812002695. doi:10.1017/S0950268812002695CrossRefPubMed
21.
go back to reference Uysal A, Taner CE, Cüce M, Atalay S, Göl B, Köse S, Uysal F: Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet. 2012, 286: 605-608. 10.1007/s00404-012-2353-z. doi:10.1007/s00404-012-2353-zCrossRefPubMed Uysal A, Taner CE, Cüce M, Atalay S, Göl B, Köse S, Uysal F: Cytomegalovirus and rubella seroprevalence in pregnant women in Izmir/Turkey: follow-up and results of pregnancy outcome. Arch Gynecol Obstet. 2012, 286: 605-608. 10.1007/s00404-012-2353-z. doi:10.1007/s00404-012-2353-zCrossRefPubMed
22.
go back to reference Akinbami AA, Rabiu KA, Adewunmi AA, Wright KO, Dosunmu AO, Adeyemo TA, Adediran A, Osunkalu VO: Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria. Int J Womens Health. 2011, 3: 423-428. doi:10.2147/IJWH.S24850CrossRefPubMedPubMedCentral Akinbami AA, Rabiu KA, Adewunmi AA, Wright KO, Dosunmu AO, Adeyemo TA, Adediran A, Osunkalu VO: Seroprevalence of cytomegalovirus antibodies amongst normal pregnant women in Nigeria. Int J Womens Health. 2011, 3: 423-428. doi:10.2147/IJWH.S24850CrossRefPubMedPubMedCentral
23.
go back to reference Correa CB, Kourí V, Verdasquera D, Martínez PA, Alvarez A, Alemán Y, Pérez L, Viera J, González R, Pérez E, Moro I, Navarro MA, Melin P: HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenat Diagn. 2010, 30: 888-892. 10.1002/pd.2587. doi:10.1002/pd.2587CrossRefPubMed Correa CB, Kourí V, Verdasquera D, Martínez PA, Alvarez A, Alemán Y, Pérez L, Viera J, González R, Pérez E, Moro I, Navarro MA, Melin P: HCMV seroprevalence and associated risk factors in pregnant women, Havana City, 2007 to 2008. Prenat Diagn. 2010, 30: 888-892. 10.1002/pd.2587. doi:10.1002/pd.2587CrossRefPubMed
24.
go back to reference Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ: Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006, 43: 1143-1151. 10.1086/508173.CrossRefPubMed Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ: Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis. 2006, 43: 1143-1151. 10.1086/508173.CrossRefPubMed
25.
go back to reference Raynor BD: Cytomegalovirus infection in pregnancy. Semin Perinatol. 1993, 17: 394-402.PubMed Raynor BD: Cytomegalovirus infection in pregnancy. Semin Perinatol. 1993, 17: 394-402.PubMed
26.
go back to reference Johnson J, Anderson B, Pass RF: Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol. 2012, 55: 521-530. 10.1097/GRF.0b013e3182510b7b. doi:10.1097/GRF.0b013e3182510b7bCrossRefPubMedPubMedCentral Johnson J, Anderson B, Pass RF: Prevention of maternal and congenital cytomegalovirus infection. Clin Obstet Gynecol. 2012, 55: 521-530. 10.1097/GRF.0b013e3182510b7b. doi:10.1097/GRF.0b013e3182510b7bCrossRefPubMedPubMedCentral
27.
go back to reference Cannon MJ, Hyde TB, Schmid DS: Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011, 21: 240-255. 10.1002/rmv.695. doi:10.1002/rmv.695CrossRefPubMedPubMedCentral Cannon MJ, Hyde TB, Schmid DS: Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011, 21: 240-255. 10.1002/rmv.695. doi:10.1002/rmv.695CrossRefPubMedPubMedCentral
Metadata
Title
Seroepidemiology of cytomegalovirus infection in pregnant women in Durango City, Mexico
Authors
Cosme Alvarado-Esquivel
Jesús Hernández-Tinoco
Luis Francisco Sánchez-Anguiano
Agar Ramos-Nevárez
Sandra Margarita Cerrillo-Soto
Sergio Estrada-Martínez
Lucio Martínez-Ramírez
Alma Rosa Pérez-Álamos
Carlos Alberto Guido-Arreola
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2014
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-484

Other articles of this Issue 1/2014

BMC Infectious Diseases 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.